(Date:12/16/2009)... /PRNewswire/ -- Capitalizing on the ... and an active venture capital market, leaders from ... Retirement Fund, Indiana University, Purdue University, the University ... Credit Suisse today announced the establishment of the ... of funds. ,, Organized through BioCrossroads, Indiana,s initiative ...
(Date:12/16/2009)... company,s revenues increase 22% for fiscal 2009; on ... , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix Biosystems ... and biological technologies, today reported financial results for ... year ended September 30, 2009, Microbix reported revenues ... same period in 2008. For fourth-quarter 2009, the ...
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/16/2009)... December 16 Eppendorf has initiated ... Verigene(R) SP systems for,infringement of European patent ... for the,identification and/or the quantification of a ... all imports of the respective products into ... are required to confiscate any,violating products. , ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2... BIRMINGHAM, Ala., June 18 BioCryst,Pharmaceuticals (Nasdaq: ... MB,BS, has been appointed Chief Medical Officer of ... seasoned biotechnology professional, most recently,serving as Vice President ... replaces interim Chief Medical Officer Dr. Tom Simon, ...
... excellence by ... communications professionals, WEST ... interactive marketing agency serving the healthcare,industry, announced today that ... Annual Communicator Awards. The Communicator Awards is the leading,international ...
... and Investment Banker Enhances ... EntreMed,s Senior Management Team, ROCKVILLE, Md., June ... company developing,therapeutics for the treatment of cancer and inflammatory diseases, ... Senior Vice,President, Corporate and Business Development. Mr. Bliss has been ...
Other Biology Technology:William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 2William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 3William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 4Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards 2Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards 3EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development 2EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development 3EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development 4When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells....
... 'SoftLinx software, a multitasking application capable ... the programming and operation of lab automation ... enough for custom modification by programmers. ... a simple drag-anddrop flowchart. If you can ...
No-Weigh Dithiothreitol (DTT) ,7.7 mg DTT/Tube x 48 tubes...
Biology Products:Biology NavigationMedical Navigation